AKT1 and inflammatory bowel disease: AdipoRon feasibly relieves IBD by aggrandizing P-AKT, PPARA, PPARG levels by AdipoR1/2 and weakening NLRP3 activities by AdipoR1. High expression of TNF-α induces low level phosphorylation of AKT (P-AKT), which aggravates IBD by increasing reactive oxygen species (ROS) and abducting apoptosis [48, 49].